Wikidata

(Q62110701)

English

Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate

clinical trial

In more languages

Statements

title
Randomized Phase II Trial of Docetaxel (Taxotere) and Oblimersen (Antisense Oligonucleotide Directed to BCL-2) Versus Taxotere Alone in Patients With Hormone-Refractory Prostate Cancer (English)
0 references
country
Austria
0 references
Belgium
0 references
Denmark
0 references
France
0 references
Israel
0 references
Italy
0 references
Netherlands
0 references
Poland
0 references
Portugal
0 references
Spain
0 references
United Kingdom
0 references
start time
April 2004
0 references
end time
January 2006
0 references
number of participants
116
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62110701&oldid=2195511421"